Genomma Lab Internacional, S.A.B. de C.V.
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Stock Competitors & Peer Comparison
See (GNMLF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| GNMLF | $0.95 | -12.04% | 928.9M | 10.56 | $0.09 | +4.59% |
| MKGAF | $148.62 | -1.80% | 67.6B | 22.92 | $6.78 | +1.66% |
| MKKGY | $30.09 | +0.84% | 65B | 22.14 | $1.35 | +1.73% |
| IPSEY | $46.60 | -4.43% | 62.1B | 30.28 | $1.55 | +0.85% |
| TKPHF | $32.10 | -1.53% | 50.7B | 42.80 | $0.75 | +4.06% |
| HLNCF | $4.63 | -3.14% | 40.9B | 18.46 | $0.25 | +2.07% |
| SDZNY | $82.20 | +0.19% | 35.8B | 39.61 | $2.09 | +1.23% |
| TEVJF | $30.19 | +0.00% | 35.2B | 24.95 | $1.21 | N/A |
| TAIPY | $14.00 | +16.67% | 18.1B | 82.35 | $0.17 | N/A |
| ESALY | $61.51 | -2.11% | 17.6B | 20.54 | $3.00 | N/A |
Stock Comparison
GNMLF vs MKGAF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, MKGAF has a market cap of 67.6B. Regarding current trading prices, GNMLF is priced at $0.95, while MKGAF trades at $148.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas MKGAF's P/E ratio is 22.92. In terms of profitability, GNMLF's ROE is +0.11%, compared to MKGAF's ROE of +0.08%. Regarding short-term risk, GNMLF is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check MKGAF's competition here
GNMLF vs MKKGY Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, MKKGY has a market cap of 65B. Regarding current trading prices, GNMLF is priced at $0.95, while MKKGY trades at $30.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas MKKGY's P/E ratio is 22.14. In terms of profitability, GNMLF's ROE is +0.11%, compared to MKKGY's ROE of +0.09%. Regarding short-term risk, GNMLF is less volatile compared to MKKGY. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check MKKGY's competition here
GNMLF vs IPSEY Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, IPSEY has a market cap of 62.1B. Regarding current trading prices, GNMLF is priced at $0.95, while IPSEY trades at $46.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas IPSEY's P/E ratio is 30.28. In terms of profitability, GNMLF's ROE is +0.11%, compared to IPSEY's ROE of +0.10%. Regarding short-term risk, GNMLF and IPSEY have similar daily volatility (0.00).Check IPSEY's competition here
GNMLF vs TKPHF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, TKPHF has a market cap of 50.7B. Regarding current trading prices, GNMLF is priced at $0.95, while TKPHF trades at $32.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas TKPHF's P/E ratio is 42.80. In terms of profitability, GNMLF's ROE is +0.11%, compared to TKPHF's ROE of +0.03%. Regarding short-term risk, GNMLF and TKPHF have similar daily volatility (0.00).Check TKPHF's competition here
GNMLF vs HLNCF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, HLNCF has a market cap of 40.9B. Regarding current trading prices, GNMLF is priced at $0.95, while HLNCF trades at $4.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas HLNCF's P/E ratio is 18.46. In terms of profitability, GNMLF's ROE is +0.11%, compared to HLNCF's ROE of +0.06%. Regarding short-term risk, GNMLF is less volatile compared to HLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check HLNCF's competition here
GNMLF vs SDZNY Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, SDZNY has a market cap of 35.8B. Regarding current trading prices, GNMLF is priced at $0.95, while SDZNY trades at $82.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas SDZNY's P/E ratio is 39.61. In terms of profitability, GNMLF's ROE is +0.11%, compared to SDZNY's ROE of +0.09%. Regarding short-term risk, GNMLF is less volatile compared to SDZNY. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check SDZNY's competition here
GNMLF vs TEVJF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, TEVJF has a market cap of 35.2B. Regarding current trading prices, GNMLF is priced at $0.95, while TEVJF trades at $30.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas TEVJF's P/E ratio is 24.95. In terms of profitability, GNMLF's ROE is +0.11%, compared to TEVJF's ROE of +0.21%. Regarding short-term risk, GNMLF and TEVJF have similar daily volatility (0.00).Check TEVJF's competition here
GNMLF vs TAIPY Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, TAIPY has a market cap of 18.1B. Regarding current trading prices, GNMLF is priced at $0.95, while TAIPY trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas TAIPY's P/E ratio is 82.35. In terms of profitability, GNMLF's ROE is +0.11%, compared to TAIPY's ROE of +0.02%. Regarding short-term risk, GNMLF is less volatile compared to TAIPY. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check TAIPY's competition here
GNMLF vs ESALY Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, GNMLF is priced at $0.95, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas ESALY's P/E ratio is 20.54. In terms of profitability, GNMLF's ROE is +0.11%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, GNMLF is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check ESALY's competition here
GNMLF vs BIOVF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, BIOVF has a market cap of 16.4B. Regarding current trading prices, GNMLF is priced at $0.95, while BIOVF trades at $47.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas BIOVF's P/E ratio is 169.11. In terms of profitability, GNMLF's ROE is +0.11%, compared to BIOVF's ROE of +0.02%. Regarding short-term risk, GNMLF and BIOVF have similar daily volatility (0.00).Check BIOVF's competition here
GNMLF vs SGIOF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, SGIOF has a market cap of 16.1B. Regarding current trading prices, GNMLF is priced at $0.95, while SGIOF trades at $18.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas SGIOF's P/E ratio is 14.99. In terms of profitability, GNMLF's ROE is +0.11%, compared to SGIOF's ROE of +0.14%. Regarding short-term risk, GNMLF and SGIOF have similar daily volatility (0.00).Check SGIOF's competition here
GNMLF vs SGIOY Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, SGIOY has a market cap of 15.9B. Regarding current trading prices, GNMLF is priced at $0.95, while SGIOY trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas SGIOY's P/E ratio is 14.80. In terms of profitability, GNMLF's ROE is +0.11%, compared to SGIOY's ROE of +0.14%. Regarding short-term risk, GNMLF is less volatile compared to SGIOY. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check SGIOY's competition here
GNMLF vs IPSEF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, IPSEF has a market cap of 9.7B. Regarding current trading prices, GNMLF is priced at $0.95, while IPSEF trades at $117.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas IPSEF's P/E ratio is 18.79. In terms of profitability, GNMLF's ROE is +0.11%, compared to IPSEF's ROE of +0.12%. Regarding short-term risk, GNMLF is less volatile compared to IPSEF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check IPSEF's competition here
GNMLF vs ESALF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, ESALF has a market cap of 7.9B. Regarding current trading prices, GNMLF is priced at $0.95, while ESALF trades at $28.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas ESALF's P/E ratio is 32.56. In terms of profitability, GNMLF's ROE is +0.11%, compared to ESALF's ROE of +0.04%. Regarding short-term risk, GNMLF and ESALF have similar daily volatility (0.00).Check ESALF's competition here
GNMLF vs ESAIY Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, ESAIY has a market cap of 7B. Regarding current trading prices, GNMLF is priced at $0.95, while ESAIY trades at $6.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas ESAIY's P/E ratio is 28.09. In terms of profitability, GNMLF's ROE is +0.11%, compared to ESAIY's ROE of +0.04%. Regarding short-term risk, GNMLF is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check ESAIY's competition here
GNMLF vs SFOSF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, SFOSF has a market cap of 6.9B. Regarding current trading prices, GNMLF is priced at $0.95, while SFOSF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas SFOSF's P/E ratio is 13.68. In terms of profitability, GNMLF's ROE is +0.11%, compared to SFOSF's ROE of +0.09%. Regarding short-term risk, GNMLF is less volatile compared to SFOSF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check SFOSF's competition here
GNMLF vs BCHMF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, BCHMF has a market cap of 6.8B. Regarding current trading prices, GNMLF is priced at $0.95, while BCHMF trades at $91.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas BCHMF's P/E ratio is 36.20. In terms of profitability, GNMLF's ROE is +0.11%, compared to BCHMF's ROE of +0.11%. Regarding short-term risk, GNMLF and BCHMF have similar daily volatility (0.00).Check BCHMF's competition here
GNMLF vs GZPHF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, GZPHF has a market cap of 6.2B. Regarding current trading prices, GNMLF is priced at $0.95, while GZPHF trades at $2.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas GZPHF's P/E ratio is 9.00. In terms of profitability, GNMLF's ROE is +0.11%, compared to GZPHF's ROE of +0.08%. Regarding short-term risk, GNMLF and GZPHF have similar daily volatility (0.00).Check GZPHF's competition here
GNMLF vs HLUBF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, HLUBF has a market cap of 5.7B. Regarding current trading prices, GNMLF is priced at $0.95, while HLUBF trades at $5.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas HLUBF's P/E ratio is 9.26. In terms of profitability, GNMLF's ROE is +0.11%, compared to HLUBF's ROE of +0.15%. Regarding short-term risk, GNMLF and HLUBF have similar daily volatility (0.00).Check HLUBF's competition here
GNMLF vs HLBBF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, HLBBF has a market cap of 5.2B. Regarding current trading prices, GNMLF is priced at $0.95, while HLBBF trades at $6.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas HLBBF's P/E ratio is 12.84. In terms of profitability, GNMLF's ROE is +0.11%, compared to HLBBF's ROE of +0.15%. Regarding short-term risk, GNMLF and HLBBF have similar daily volatility (0.00).Check HLBBF's competition here
GNMLF vs LVZPF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, LVZPF has a market cap of 5.1B. Regarding current trading prices, GNMLF is priced at $0.95, while LVZPF trades at $4.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas LVZPF's P/E ratio is 12.79. In terms of profitability, GNMLF's ROE is +0.11%, compared to LVZPF's ROE of +0.14%. Regarding short-term risk, GNMLF and LVZPF have similar daily volatility (0.00).Check LVZPF's competition here
GNMLF vs SMDPY Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, SMDPY has a market cap of 4.9B. Regarding current trading prices, GNMLF is priced at $0.95, while SMDPY trades at $10.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas SMDPY's P/E ratio is 6.47. In terms of profitability, GNMLF's ROE is +0.11%, compared to SMDPY's ROE of +0.42%. Regarding short-term risk, GNMLF is less volatile compared to SMDPY. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check SMDPY's competition here
GNMLF vs DNPUF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, DNPUF has a market cap of 4.7B. Regarding current trading prices, GNMLF is priced at $0.95, while DNPUF trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas DNPUF's P/E ratio is 6.21. In terms of profitability, GNMLF's ROE is +0.11%, compared to DNPUF's ROE of +0.42%. Regarding short-term risk, GNMLF and DNPUF have similar daily volatility (0.00).Check DNPUF's competition here
GNMLF vs LABFF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, GNMLF is priced at $0.95, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas LABFF's P/E ratio is 28.95. In terms of profitability, GNMLF's ROE is +0.11%, compared to LABFF's ROE of +0.21%. Regarding short-term risk, GNMLF and LABFF have similar daily volatility (0.00).Check LABFF's competition here
GNMLF vs SGFEF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, SGFEF has a market cap of 4.4B. Regarding current trading prices, GNMLF is priced at $0.95, while SGFEF trades at $100.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas SGFEF's P/E ratio is 20.49. In terms of profitability, GNMLF's ROE is +0.11%, compared to SGFEF's ROE of +0.16%. Regarding short-term risk, GNMLF is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check SGFEF's competition here
GNMLF vs HKMPY Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, HKMPY has a market cap of 4.3B. Regarding current trading prices, GNMLF is priced at $0.95, while HKMPY trades at $39.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas HKMPY's P/E ratio is 10.83. In terms of profitability, GNMLF's ROE is +0.11%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, GNMLF and HKMPY have similar daily volatility (0.00).Check HKMPY's competition here
GNMLF vs HKMPF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, HKMPF has a market cap of 4.3B. Regarding current trading prices, GNMLF is priced at $0.95, while HKMPF trades at $19.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas HKMPF's P/E ratio is 11.02. In terms of profitability, GNMLF's ROE is +0.11%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, GNMLF and HKMPF have similar daily volatility (0.00).Check HKMPF's competition here
GNMLF vs APNHY Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, APNHY has a market cap of 3.7B. Regarding current trading prices, GNMLF is priced at $0.95, while APNHY trades at $8.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas APNHY's P/E ratio is -33.60. In terms of profitability, GNMLF's ROE is +0.11%, compared to APNHY's ROE of -0.02%. Regarding short-term risk, GNMLF and APNHY have similar daily volatility (0.00).Check APNHY's competition here
GNMLF vs APNHF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, APNHF has a market cap of 3.6B. Regarding current trading prices, GNMLF is priced at $0.95, while APNHF trades at $8.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas APNHF's P/E ratio is -32.80. In terms of profitability, GNMLF's ROE is +0.11%, compared to APNHF's ROE of -0.02%. Regarding short-term risk, GNMLF and APNHF have similar daily volatility (0.00).Check APNHF's competition here
GNMLF vs LBTSF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, LBTSF has a market cap of 3.3B. Regarding current trading prices, GNMLF is priced at $0.95, while LBTSF trades at $15.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas LBTSF's P/E ratio is 59.04. In terms of profitability, GNMLF's ROE is +0.11%, compared to LBTSF's ROE of +0.04%. Regarding short-term risk, GNMLF and LBTSF have similar daily volatility (0.00).Check LBTSF's competition here
GNMLF vs CAMRF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, CAMRF has a market cap of 3.3B. Regarding current trading prices, GNMLF is priced at $0.95, while CAMRF trades at $55.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas CAMRF's P/E ratio is 45.08. In terms of profitability, GNMLF's ROE is +0.11%, compared to CAMRF's ROE of +0.16%. Regarding short-term risk, GNMLF and CAMRF have similar daily volatility (0.00).Check CAMRF's competition here
GNMLF vs HYPMY Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, HYPMY has a market cap of 3.1B. Regarding current trading prices, GNMLF is priced at $0.95, while HYPMY trades at $4.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas HYPMY's P/E ratio is 8.44. In terms of profitability, GNMLF's ROE is +0.11%, compared to HYPMY's ROE of +0.13%. Regarding short-term risk, GNMLF is less volatile compared to HYPMY. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check HYPMY's competition here
GNMLF vs INVVY Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, GNMLF is priced at $0.95, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas INVVY's P/E ratio is -62.42. In terms of profitability, GNMLF's ROE is +0.11%, compared to INVVY's ROE of -0.42%. Regarding short-term risk, GNMLF and INVVY have similar daily volatility (0.00).Check INVVY's competition here
GNMLF vs DMPHF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, DMPHF has a market cap of 2.9B. Regarding current trading prices, GNMLF is priced at $0.95, while DMPHF trades at $59.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas DMPHF's P/E ratio is 26.70. In terms of profitability, GNMLF's ROE is +0.11%, compared to DMPHF's ROE of +0.21%. Regarding short-term risk, GNMLF and DMPHF have similar daily volatility (0.00).Check DMPHF's competition here
GNMLF vs IZQVF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, GNMLF is priced at $0.95, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, GNMLF's ROE is +0.11%, compared to IZQVF's ROE of -0.99%. Regarding short-term risk, GNMLF and IZQVF have similar daily volatility (0.00).Check IZQVF's competition here
GNMLF vs CURLF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, CURLF has a market cap of 2.6B. Regarding current trading prices, GNMLF is priced at $0.95, while CURLF trades at $3.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas CURLF's P/E ratio is -23.36. In terms of profitability, GNMLF's ROE is +0.11%, compared to CURLF's ROE of -0.13%. Regarding short-term risk, GNMLF is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check CURLF's competition here
GNMLF vs ULIHF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, ULIHF has a market cap of 2.6B. Regarding current trading prices, GNMLF is priced at $0.95, while ULIHF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas ULIHF's P/E ratio is 8.13. In terms of profitability, GNMLF's ROE is +0.11%, compared to ULIHF's ROE of +0.13%. Regarding short-term risk, GNMLF and ULIHF have similar daily volatility (0.00).Check ULIHF's competition here
GNMLF vs CHSYF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, CHSYF has a market cap of 2.3B. Regarding current trading prices, GNMLF is priced at $0.95, while CHSYF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas CHSYF's P/E ratio is 9.31. In terms of profitability, GNMLF's ROE is +0.11%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, GNMLF and CHSYF have similar daily volatility (0.00).Check CHSYF's competition here
GNMLF vs NPNKF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, NPNKF has a market cap of 2.2B. Regarding current trading prices, GNMLF is priced at $0.95, while NPNKF trades at $32.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas NPNKF's P/E ratio is 11.78. In terms of profitability, GNMLF's ROE is +0.11%, compared to NPNKF's ROE of +0.11%. Regarding short-term risk, GNMLF and NPNKF have similar daily volatility (0.00).Check NPNKF's competition here
GNMLF vs TSMRF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, TSMRF has a market cap of 2.1B. Regarding current trading prices, GNMLF is priced at $0.95, while TSMRF trades at $28.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas TSMRF's P/E ratio is 12.19. In terms of profitability, GNMLF's ROE is +0.11%, compared to TSMRF's ROE of +0.09%. Regarding short-term risk, GNMLF and TSMRF have similar daily volatility (0.00).Check TSMRF's competition here
GNMLF vs HTSUF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, HTSUF has a market cap of 2B. Regarding current trading prices, GNMLF is priced at $0.95, while HTSUF trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas HTSUF's P/E ratio is 16.76. In terms of profitability, GNMLF's ROE is +0.11%, compared to HTSUF's ROE of +0.07%. Regarding short-term risk, GNMLF and HTSUF have similar daily volatility (0.00).Check HTSUF's competition here
GNMLF vs ARSUF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, ARSUF has a market cap of 2B. Regarding current trading prices, GNMLF is priced at $0.95, while ARSUF trades at $27.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas ARSUF's P/E ratio is 18.75. In terms of profitability, GNMLF's ROE is +0.11%, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, GNMLF and ARSUF have similar daily volatility (0.00).Check ARSUF's competition here
GNMLF vs DUTV Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, DUTV has a market cap of 1.9B. Regarding current trading prices, GNMLF is priced at $0.95, while DUTV trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas DUTV's P/E ratio is N/A. In terms of profitability, GNMLF's ROE is +0.11%, compared to DUTV's ROE of -0.04%. Regarding short-term risk, GNMLF is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check DUTV's competition here
GNMLF vs HMDCF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, HMDCF has a market cap of 1.9B. Regarding current trading prices, GNMLF is priced at $0.95, while HMDCF trades at $2.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas HMDCF's P/E ratio is 4.08. In terms of profitability, GNMLF's ROE is +0.11%, compared to HMDCF's ROE of +0.41%. Regarding short-term risk, GNMLF is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check HMDCF's competition here
GNMLF vs NPPNY Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, NPPNY has a market cap of 1.8B. Regarding current trading prices, GNMLF is priced at $0.95, while NPPNY trades at $6.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas NPPNY's P/E ratio is 9.65. In terms of profitability, GNMLF's ROE is +0.11%, compared to NPPNY's ROE of +0.11%. Regarding short-term risk, GNMLF is less volatile compared to NPPNY. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check NPPNY's competition here
GNMLF vs GTBIF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, GTBIF has a market cap of 1.7B. Regarding current trading prices, GNMLF is priced at $0.95, while GTBIF trades at $7.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas GTBIF's P/E ratio is 14.43. In terms of profitability, GNMLF's ROE is +0.11%, compared to GTBIF's ROE of +0.07%. Regarding short-term risk, GNMLF is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check GTBIF's competition here
GNMLF vs SHPHF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, SHPHF has a market cap of 1.7B. Regarding current trading prices, GNMLF is priced at $0.95, while SHPHF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas SHPHF's P/E ratio is -6.22. In terms of profitability, GNMLF's ROE is +0.11%, compared to SHPHF's ROE of +0.03%. Regarding short-term risk, GNMLF and SHPHF have similar daily volatility (0.00).Check SHPHF's competition here
GNMLF vs CMOPF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, CMOPF has a market cap of 1.6B. Regarding current trading prices, GNMLF is priced at $0.95, while CMOPF trades at $103.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas CMOPF's P/E ratio is -387.13. In terms of profitability, GNMLF's ROE is +0.11%, compared to CMOPF's ROE of -0.01%. Regarding short-term risk, GNMLF is less volatile compared to CMOPF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check CMOPF's competition here
GNMLF vs MITPF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, GNMLF is priced at $0.95, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas MITPF's P/E ratio is -10.81. In terms of profitability, GNMLF's ROE is +0.11%, compared to MITPF's ROE of +4.99%. Regarding short-term risk, GNMLF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check MITPF's competition here
GNMLF vs TCNNF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, TCNNF has a market cap of 1.6B. Regarding current trading prices, GNMLF is priced at $0.95, while TCNNF trades at $8.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas TCNNF's P/E ratio is -20.27. In terms of profitability, GNMLF's ROE is +0.11%, compared to TCNNF's ROE of -0.07%. Regarding short-term risk, GNMLF is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check TCNNF's competition here
GNMLF vs KARBF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, GNMLF is priced at $0.95, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas KARBF's P/E ratio is 262.50. In terms of profitability, GNMLF's ROE is +0.11%, compared to KARBF's ROE of N/A. Regarding short-term risk, GNMLF and KARBF have similar daily volatility (0.00).Check KARBF's competition here
GNMLF vs CASBF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, CASBF has a market cap of 1.4B. Regarding current trading prices, GNMLF is priced at $0.95, while CASBF trades at $3.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas CASBF's P/E ratio is 198.50. In terms of profitability, GNMLF's ROE is +0.11%, compared to CASBF's ROE of -0.00%. Regarding short-term risk, GNMLF is less volatile compared to CASBF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check CASBF's competition here
GNMLF vs CHIZF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, GNMLF is priced at $0.95, while CHIZF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas CHIZF's P/E ratio is -27.34. In terms of profitability, GNMLF's ROE is +0.11%, compared to CHIZF's ROE of -0.01%. Regarding short-term risk, GNMLF and CHIZF have similar daily volatility (0.00).Check CHIZF's competition here
GNMLF vs SWGHF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, SWGHF has a market cap of 1.3B. Regarding current trading prices, GNMLF is priced at $0.95, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, GNMLF's ROE is +0.11%, compared to SWGHF's ROE of +0.06%. Regarding short-term risk, GNMLF and SWGHF have similar daily volatility (0.00).Check SWGHF's competition here
GNMLF vs KSPHF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, KSPHF has a market cap of 1.3B. Regarding current trading prices, GNMLF is priced at $0.95, while KSPHF trades at $30.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas KSPHF's P/E ratio is 14.49. In terms of profitability, GNMLF's ROE is +0.11%, compared to KSPHF's ROE of +0.06%. Regarding short-term risk, GNMLF and KSPHF have similar daily volatility (0.00).Check KSPHF's competition here
GNMLF vs TWAPF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, TWAPF has a market cap of 1.2B. Regarding current trading prices, GNMLF is priced at $0.95, while TWAPF trades at $25.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas TWAPF's P/E ratio is 9.45. In terms of profitability, GNMLF's ROE is +0.11%, compared to TWAPF's ROE of +0.03%. Regarding short-term risk, GNMLF and TWAPF have similar daily volatility (0.00).Check TWAPF's competition here
GNMLF vs EVOTF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, EVOTF has a market cap of 1.2B. Regarding current trading prices, GNMLF is priced at $0.95, while EVOTF trades at $6.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas EVOTF's P/E ratio is -5.27. In terms of profitability, GNMLF's ROE is +0.11%, compared to EVOTF's ROE of -0.25%. Regarding short-term risk, GNMLF is less volatile compared to EVOTF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check EVOTF's competition here
GNMLF vs LJUIF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, LJUIF has a market cap of 1.2B. Regarding current trading prices, GNMLF is priced at $0.95, while LJUIF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas LJUIF's P/E ratio is 13.42. In terms of profitability, GNMLF's ROE is +0.11%, compared to LJUIF's ROE of +0.06%. Regarding short-term risk, GNMLF is less volatile compared to LJUIF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check LJUIF's competition here
GNMLF vs BIOGY Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, BIOGY has a market cap of 1.1B. Regarding current trading prices, GNMLF is priced at $0.95, while BIOGY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas BIOGY's P/E ratio is 31.43. In terms of profitability, GNMLF's ROE is +0.11%, compared to BIOGY's ROE of +0.26%. Regarding short-term risk, GNMLF and BIOGY have similar daily volatility (0.00).Check BIOGY's competition here
GNMLF vs SHEZF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, SHEZF has a market cap of 1.1B. Regarding current trading prices, GNMLF is priced at $0.95, while SHEZF trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas SHEZF's P/E ratio is -36.03. In terms of profitability, GNMLF's ROE is +0.11%, compared to SHEZF's ROE of +0.03%. Regarding short-term risk, GNMLF and SHEZF have similar daily volatility (0.00).Check SHEZF's competition here
GNMLF vs KKPCF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, KKPCF has a market cap of 1B. Regarding current trading prices, GNMLF is priced at $0.95, while KKPCF trades at $26.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas KKPCF's P/E ratio is 297.56. In terms of profitability, GNMLF's ROE is +0.11%, compared to KKPCF's ROE of +0.01%. Regarding short-term risk, GNMLF is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check KKPCF's competition here
GNMLF vs GLASF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, GLASF has a market cap of 847M. Regarding current trading prices, GNMLF is priced at $0.95, while GLASF trades at $10.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas GLASF's P/E ratio is -16.83. In terms of profitability, GNMLF's ROE is +0.11%, compared to GLASF's ROE of -0.26%. Regarding short-term risk, GNMLF is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check GLASF's competition here
GNMLF vs CSWYF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, CSWYF has a market cap of 815.8M. Regarding current trading prices, GNMLF is priced at $0.95, while CSWYF trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas CSWYF's P/E ratio is 5.14. In terms of profitability, GNMLF's ROE is +0.11%, compared to CSWYF's ROE of +0.12%. Regarding short-term risk, GNMLF is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check CSWYF's competition here
GNMLF vs TRXPF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, GNMLF is priced at $0.95, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, GNMLF's ROE is +0.11%, compared to TRXPF's ROE of +0.03%. Regarding short-term risk, GNMLF and TRXPF have similar daily volatility (0.00).Check TRXPF's competition here
GNMLF vs YIHCF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, GNMLF is priced at $0.95, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, GNMLF's ROE is +0.11%, compared to YIHCF's ROE of +0.06%. Regarding short-term risk, GNMLF and YIHCF have similar daily volatility (0.00).Check YIHCF's competition here
GNMLF vs AIHLF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, AIHLF has a market cap of 624.3M. Regarding current trading prices, GNMLF is priced at $0.95, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas AIHLF's P/E ratio is 10.94. In terms of profitability, GNMLF's ROE is +0.11%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, GNMLF and AIHLF have similar daily volatility (0.00).Check AIHLF's competition here
GNMLF vs TRSSF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, GNMLF is priced at $0.95, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, GNMLF's ROE is +0.11%, compared to TRSSF's ROE of -0.75%. Regarding short-term risk, GNMLF is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check TRSSF's competition here
GNMLF vs KHTRF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, KHTRF has a market cap of 589.2M. Regarding current trading prices, GNMLF is priced at $0.95, while KHTRF trades at $6.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas KHTRF's P/E ratio is 150.25. In terms of profitability, GNMLF's ROE is +0.11%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, GNMLF and KHTRF have similar daily volatility (0.00).Check KHTRF's competition here
GNMLF vs SWDCF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, SWDCF has a market cap of 575.4M. Regarding current trading prices, GNMLF is priced at $0.95, while SWDCF trades at $3.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas SWDCF's P/E ratio is 120.00. In terms of profitability, GNMLF's ROE is +0.11%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, GNMLF and SWDCF have similar daily volatility (0.00).Check SWDCF's competition here
GNMLF vs AGYTF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, AGYTF has a market cap of 554.6M. Regarding current trading prices, GNMLF is priced at $0.95, while AGYTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas AGYTF's P/E ratio is -11.00. In terms of profitability, GNMLF's ROE is +0.11%, compared to AGYTF's ROE of +2.84%. Regarding short-term risk, GNMLF and AGYTF have similar daily volatility (0.00).Check AGYTF's competition here
GNMLF vs BOIRF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, BOIRF has a market cap of 553.9M. Regarding current trading prices, GNMLF is priced at $0.95, while BOIRF trades at $31.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas BOIRF's P/E ratio is 24.17. In terms of profitability, GNMLF's ROE is +0.11%, compared to BOIRF's ROE of +0.05%. Regarding short-term risk, GNMLF is less volatile compared to BOIRF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check BOIRF's competition here
GNMLF vs PKBFF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, PKBFF has a market cap of 544.7M. Regarding current trading prices, GNMLF is priced at $0.95, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas PKBFF's P/E ratio is N/A. In terms of profitability, GNMLF's ROE is +0.11%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, GNMLF and PKBFF have similar daily volatility (0.00).Check PKBFF's competition here
GNMLF vs NIKA Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, NIKA has a market cap of 534.8M. Regarding current trading prices, GNMLF is priced at $0.95, while NIKA trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas NIKA's P/E ratio is N/A. In terms of profitability, GNMLF's ROE is +0.11%, compared to NIKA's ROE of +0.27%. Regarding short-term risk, GNMLF and NIKA have similar daily volatility (0.00).Check NIKA's competition here
GNMLF vs CCHWF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, GNMLF is priced at $0.95, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, GNMLF's ROE is +0.11%, compared to CCHWF's ROE of +0.42%. Regarding short-term risk, GNMLF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check CCHWF's competition here
GNMLF vs VRNOF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, VRNOF has a market cap of 470.4M. Regarding current trading prices, GNMLF is priced at $0.95, while VRNOF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas VRNOF's P/E ratio is -1.31. In terms of profitability, GNMLF's ROE is +0.11%, compared to VRNOF's ROE of -0.31%. Regarding short-term risk, GNMLF is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check VRNOF's competition here
GNMLF vs PEXXF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, GNMLF is priced at $0.95, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, GNMLF's ROE is +0.11%, compared to PEXXF's ROE of N/A. Regarding short-term risk, GNMLF and PEXXF have similar daily volatility (0.00).Check PEXXF's competition here
GNMLF vs HUMDF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, HUMDF has a market cap of 409.3M. Regarding current trading prices, GNMLF is priced at $0.95, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas HUMDF's P/E ratio is 2.57. In terms of profitability, GNMLF's ROE is +0.11%, compared to HUMDF's ROE of +1.07%. Regarding short-term risk, GNMLF and HUMDF have similar daily volatility (0.00).Check HUMDF's competition here
GNMLF vs ELTP Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, ELTP has a market cap of 373.4M. Regarding current trading prices, GNMLF is priced at $0.95, while ELTP trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas ELTP's P/E ratio is 8.67. In terms of profitability, GNMLF's ROE is +0.11%, compared to ELTP's ROE of +0.71%. Regarding short-term risk, GNMLF is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check ELTP's competition here
GNMLF vs CRLBF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, CRLBF has a market cap of 312M. Regarding current trading prices, GNMLF is priced at $0.95, while CRLBF trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas CRLBF's P/E ratio is -2.39. In terms of profitability, GNMLF's ROE is +0.11%, compared to CRLBF's ROE of -0.35%. Regarding short-term risk, GNMLF is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check CRLBF's competition here
GNMLF vs CPHRF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, CPHRF has a market cap of 300.2M. Regarding current trading prices, GNMLF is priced at $0.95, while CPHRF trades at $11.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas CPHRF's P/E ratio is 9.98. In terms of profitability, GNMLF's ROE is +0.11%, compared to CPHRF's ROE of +0.26%. Regarding short-term risk, GNMLF is less volatile compared to CPHRF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check CPHRF's competition here
GNMLF vs GUERF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, GUERF has a market cap of 281M. Regarding current trading prices, GNMLF is priced at $0.95, while GUERF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas GUERF's P/E ratio is 8.19. In terms of profitability, GNMLF's ROE is +0.11%, compared to GUERF's ROE of +0.04%. Regarding short-term risk, GNMLF and GUERF have similar daily volatility (0.00).Check GUERF's competition here
GNMLF vs BHCCF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, GNMLF is priced at $0.95, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, GNMLF's ROE is +0.11%, compared to BHCCF's ROE of +0.29%. Regarding short-term risk, GNMLF is less volatile compared to BHCCF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check BHCCF's competition here
GNMLF vs PLNHF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, GNMLF is priced at $0.95, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, GNMLF's ROE is +0.11%, compared to PLNHF's ROE of +838111.55%. Regarding short-term risk, GNMLF is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check PLNHF's competition here
GNMLF vs CBWTF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, CBWTF has a market cap of 150.7M. Regarding current trading prices, GNMLF is priced at $0.95, while CBWTF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas CBWTF's P/E ratio is 10.74. In terms of profitability, GNMLF's ROE is +0.11%, compared to CBWTF's ROE of +0.16%. Regarding short-term risk, GNMLF is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check CBWTF's competition here
GNMLF vs COPHF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, GNMLF is priced at $0.95, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas COPHF's P/E ratio is -0.02. In terms of profitability, GNMLF's ROE is +0.11%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, GNMLF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check COPHF's competition here
GNMLF vs NWPN Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, GNMLF is priced at $0.95, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas NWPN's P/E ratio is -0.04. In terms of profitability, GNMLF's ROE is +0.11%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, GNMLF is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check NWPN's competition here
GNMLF vs LOVFF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, LOVFF has a market cap of 122.5M. Regarding current trading prices, GNMLF is priced at $0.95, while LOVFF trades at $1.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas LOVFF's P/E ratio is 15.50. In terms of profitability, GNMLF's ROE is +0.11%, compared to LOVFF's ROE of +0.09%. Regarding short-term risk, GNMLF and LOVFF have similar daily volatility (0.00).Check LOVFF's competition here
GNMLF vs BIOYF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, BIOYF has a market cap of 117.3M. Regarding current trading prices, GNMLF is priced at $0.95, while BIOYF trades at $10.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas BIOYF's P/E ratio is 17.89. In terms of profitability, GNMLF's ROE is +0.11%, compared to BIOYF's ROE of +0.22%. Regarding short-term risk, GNMLF is less volatile compared to BIOYF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check BIOYF's competition here
GNMLF vs LPCUF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, LPCUF has a market cap of 110.8M. Regarding current trading prices, GNMLF is priced at $0.95, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas LPCUF's P/E ratio is 9.41. In terms of profitability, GNMLF's ROE is +0.11%, compared to LPCUF's ROE of +0.06%. Regarding short-term risk, GNMLF is less volatile compared to LPCUF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check LPCUF's competition here
GNMLF vs CNVCF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, GNMLF is priced at $0.95, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, GNMLF's ROE is +0.11%, compared to CNVCF's ROE of +1.21%. Regarding short-term risk, GNMLF and CNVCF have similar daily volatility (0.00).Check CNVCF's competition here
GNMLF vs AAWH Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, AAWH has a market cap of 108.6M. Regarding current trading prices, GNMLF is priced at $0.95, while AAWH trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas AAWH's P/E ratio is -0.84. In terms of profitability, GNMLF's ROE is +0.11%, compared to AAWH's ROE of +5.41%. Regarding short-term risk, GNMLF is less volatile compared to AAWH. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check AAWH's competition here
GNMLF vs HLTRF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, HLTRF has a market cap of 102M. Regarding current trading prices, GNMLF is priced at $0.95, while HLTRF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas HLTRF's P/E ratio is -10.19. In terms of profitability, GNMLF's ROE is +0.11%, compared to HLTRF's ROE of -0.17%. Regarding short-term risk, GNMLF is less volatile compared to HLTRF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check HLTRF's competition here
GNMLF vs ORXOF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, ORXOF has a market cap of 101.9M. Regarding current trading prices, GNMLF is priced at $0.95, while ORXOF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas ORXOF's P/E ratio is -2.27. In terms of profitability, GNMLF's ROE is +0.11%, compared to ORXOF's ROE of -2.28%. Regarding short-term risk, GNMLF and ORXOF have similar daily volatility (0.00).Check ORXOF's competition here
GNMLF vs GRUSF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, GRUSF has a market cap of 98.6M. Regarding current trading prices, GNMLF is priced at $0.95, while GRUSF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas GRUSF's P/E ratio is 39.46. In terms of profitability, GNMLF's ROE is +0.11%, compared to GRUSF's ROE of +0.01%. Regarding short-term risk, GNMLF is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check GRUSF's competition here
GNMLF vs JUSHF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, JUSHF has a market cap of 97M. Regarding current trading prices, GNMLF is priced at $0.95, while JUSHF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas JUSHF's P/E ratio is -1.35. In terms of profitability, GNMLF's ROE is +0.11%, compared to JUSHF's ROE of +0.66%. Regarding short-term risk, GNMLF is less volatile compared to JUSHF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check JUSHF's competition here
GNMLF vs MEDXF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, MEDXF has a market cap of 91.1M. Regarding current trading prices, GNMLF is priced at $0.95, while MEDXF trades at $2.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas MEDXF's P/E ratio is -141.00. In terms of profitability, GNMLF's ROE is +0.11%, compared to MEDXF's ROE of -0.01%. Regarding short-term risk, GNMLF is less volatile compared to MEDXF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check MEDXF's competition here
GNMLF vs SHIEF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, SHIEF has a market cap of 85.5M. Regarding current trading prices, GNMLF is priced at $0.95, while SHIEF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas SHIEF's P/E ratio is -4.00. In terms of profitability, GNMLF's ROE is +0.11%, compared to SHIEF's ROE of +1.01%. Regarding short-term risk, GNMLF and SHIEF have similar daily volatility (0.00).Check SHIEF's competition here
GNMLF vs ABSCF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, ABSCF has a market cap of 78.1M. Regarding current trading prices, GNMLF is priced at $0.95, while ABSCF trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas ABSCF's P/E ratio is -37.33. In terms of profitability, GNMLF's ROE is +0.11%, compared to ABSCF's ROE of +0.07%. Regarding short-term risk, GNMLF is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check ABSCF's competition here
GNMLF vs CWBHF Comparison May 2026
GNMLF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GNMLF stands at 928.9M. In comparison, CWBHF has a market cap of 73.9M. Regarding current trading prices, GNMLF is priced at $0.95, while CWBHF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GNMLF currently has a P/E ratio of 10.56, whereas CWBHF's P/E ratio is -2.00. In terms of profitability, GNMLF's ROE is +0.11%, compared to CWBHF's ROE of -20.65%. Regarding short-term risk, GNMLF is less volatile compared to CWBHF. This indicates potentially lower risk in terms of short-term price fluctuations for GNMLF.Check CWBHF's competition here